We are live on ! Find out more
FLGT icon

Fulgent Genetics

196 hedge funds and large institutions have $509M invested in Fulgent Genetics in 2020 Q4 according to their latest regulatory filings, with 88 funds opening new positions, 69 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

418% more first-time investments, than exits

New positions opened: 88 | Existing positions closed: 17

146% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 28

59% more capital invested

Capital invested by funds: $321M → $509M (+$188M)

56% more funds holding

Funds holding: 126196 (+70)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

3.58% more ownership

Funds ownership: 36.56%40.14% (+3.6%)

33% less call options, than puts

Call options by funds: $33.6M | Put options by funds: $50.2M

Holders
196
Holders Change
+70
Holders Change %
+55.56%
% of All Funds
3.47%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
88
Increased
69
Reduced
28
Closed
17
Calls
$33.6M
Puts
$50.2M
Net Calls
-$16.6M
Net Calls Change
-$18.2M

FLGT Hedge Fund Activity: Q4 2020 in Review

196 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q4 2020, worth a combined $509M — up 59% from $321M a quarter earlier.

Buyers outnumbered sellers: 88 funds opened new FLGT positions and 17 closed out — a net gain of 71 holders — while 69 added to existing stakes and 28 trimmed.

The largest buyer was BlackRock, adding an estimated $16.6M. The largest seller was Raymond James Trust, cutting an estimated $37.7M.

  • 196 institutional investors held Fulgent Genetics (FLGT) as of Q4 2020, up from 126 in Q3 2020.
  • Funds reported $509M of Fulgent Genetics stock for Q4 2020, up 59% quarter-over-quarter.
  • 88 funds opened new Fulgent Genetics positions in Q4 2020 and 17 closed out, a net change of +71 holders.
  • The largest Fulgent Genetics buyer in Q4 2020 was BlackRock, an estimated $16.6M added.
  • The largest Fulgent Genetics seller in Q4 2020 was Raymond James Trust, an estimated $37.7M sold.

Based on aggregated 13F filings for Q4 2020.